Sens. Mark Warner and Bill Cassidy reintroduced bipartisan legislation on September 29 to expand federal drug acquisition cost surveys to specialty and mail-order pharmacies. The senators argue better reimbursement data would improve payment policy and help protect patients from higher out-of-pocket costs. The bill has implications for both Medicare and Medicaid drug reimbursement debates.
